ÂÜÀòÂÒÂ×

Hedi Ben Brahim is the Chairman & Chief Executive Officer of Transgene. He joined Transgene from Institut Mérieux where he was Vice-President for Immunotherapy. He also is the Chairman of ABL Inc., a contract research & development, and contract biomanufacturing organization (CRO/CMO). Prior to joining the Institut Mérieux, he was General Manager at a subsidiary of Vallourec, a solutions provider to the energy sector. Hedi Ben Brahim began his career in the public sector at the Ministry of the Economy, Action and Public Accounts, then at the Ministry of Social Affairs and Health. He is a graduate of the École Polytechnique and the École Nationale Supérieure des Mines de Paris.